(MENAFN- IMARC Group)
IMARC Group's report titled“ Protein Hydrolysate Ingredient market Report by Type (Milk Protein Hydrolysate, plant Protein Hydrolysate, Animal Protein Hydrolysate), Product Form (Powder, Liquid, Bar), Application (Infant Formula, Sports Nutrition, Clinical Nutrition, and Others), and Region 2024-2032 “, The global protein hydrolysate ingredientmarket size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.3% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/protein-hydrolysate-ingredient-market/requestsample
Factors Affecting the Growth of the Protein Hydrolysate Ingredient Industry:
Growing Demand for Infant Nutrition Products:
The increasing need for infant nutrition products is driving the demand for protein hydrolysates, which are partially digested proteins and easier for infants to absorb compared to intact proteins. This makes them a key ingredient in infant formulas designed to mimic the nutritional profile of breast milk, offering an optimal balance of nutrients for the development of the infant. The rising awareness among parents about the significance of nutrition in early childhood, coupled with the growing number of working mothers, is catalyzing the demand for high-quality, convenient infant nutrition products. Additionally, the prevalence of allergies and lactose intolerance among infants is prompting manufacturers to innovate and expand their offerings of hypoallergenic infant formulas.
Technological Advancements in Enzymatic Hydrolysis:
Enzymatic hydrolysis is a method used to produce protein hydrolysates, involving the breaking down of proteins into smaller peptides and amino acids utilizing enzymes. Improvements in this technology are enabling the production of protein hydrolysates with specific peptide profiles and enhanced functionalities, such as improved solubility, taste, and digestibility. These advancements are extending the application range of protein hydrolysates beyond traditional usage, making them suitable for use in a wider array of food and beverage products, including sports nutrition, infant nutrition, and medical nutrition. Moreover, the ability to customize the hydrolysis process to produce ingredients with targeted nutritional and functional properties is opening new opportunities for product differentiation and innovation.
Clinical Nutrition and Medical Applications:
Protein hydrolysate ingredients play a crucial role in formulating enteral nutrition products designed to support patients who are unable to consume food orally. Protein hydrolysates are particularly valued in clinical settings for their easy digestibility and ability to provide essential nutrients in a more absorbable form, which is crucial for patients with compromised digestive systems. The rising geriatric population and the increasing occurrence of chronic conditions, such as cancer and gastrointestinal disorders, are driving the need for effective clinical nutrition solutions.
Leading Companies Operating in the Global Protein Hydrolysate Ingredient Industry:
A. Costantino & C. spa Abbott Laboratories Agropur Coopérative AMCO Proteins Arla Foods amba Armor Protéines (Savencia Fromage & Dairy) Carbery Group Limited Fonterra Co-operative Group Limited Glanbia PLC Hilmar Ingredients Kerry Group plc Milk Specialties Global Nestlé S.A. Royal FrieslandCampina N.V. (Zuivelcooperatie FrieslandCampina U.A.).
Protein Hydrolysate Ingredient Market Report Segmentation:
By Type:
Milk Protein Hydrolysate Plant Protein Hydrolysate Animal Protein Hydrolysate
Milk protein hydrolysate holds the biggest market share due to its wide acceptance for its nutritional benefits and hypoallergenic properties.
By Product Form:
Powder exhibits a clear dominance in the market owing to its convenience in storage and transportation, ease of use in a wide range of food and beverage applications, and superior solubility.
By Application:
Infant Formula Sports Nutrition Clinical Nutrition Others
Infant formula represents the largest segment, as protein hydrolysates are often used to reduce the risk of allergy in infants, providing a safer alternative to animal milk-based formulas.
Regional Insights:
North America (United States, Canada) Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others) Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others) Latin America (Brazil, Mexico, Others) Middle East and Africa
Region-wise, the market has been segmented into North America (United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
Global Protein Hydrolysate Ingredient Market Trends:
Personalized nutrition, which tailors dietary recommendations and products to individual health needs, genetic profiles, and lifestyle choices, is becoming popular among health-conscious consumers. This trend is fostering innovation in the development of functional foods and beverages that are fortified with protein hydrolysates, aimed at addressing specific health concerns like immune support, gut health, and metabolic health. Protein hydrolysates, with their enhanced digestibility and bioavailability, are ideal for formulating these targeted nutritional solutions.
Furthermore, the convergence of food technology and biotechnology is enabling the creation of protein hydrolysates with optimized functional properties and health benefits, broadening their application in the nutraceutical sector.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email:
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
MENAFN28022024004122016232ID1107909559
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.